Subarachnoid Hemorrhage Surgical Devices Market Analysis

  • Report ID: 3333
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Subarachnoid Hemorrhage Surgical Devices Market Analysis

The global subarachnoid hemorrhage surgical devices market is divided by surgery type into endovascular surgery, and open surgery, out of which, the endovascular surgery segment is anticipated to hold the notable revenue share in the market during the forecast period as this is minimally invasive and less risky as compared to open surgery, which is why people prefer it, if the condition allows. However, the surgery depends on the condition of the patients.

On the basis of end-user, the subarachnoid hemorrhage surgical devices market is segmented into hospitals, ambulatory surgical centers, and others, out of which the ambulatory surgical centers segment is anticipated to grow significantly throughout the forecast period. This can be attributed to the growing acceptance of ASCs as they are less expensive, specialized, and better equipped for surgeries. Moreover, this segment is expected to witness growth in developed nations, owing to higher health awareness amongst the people, whereas, hospital segment is estimated to dominate the market in developing countries.

Our in-depth analysis of the global market includes the following segments

            By Device Type

 

  • Flow Diversion Device
  • Microsurgical Clips
  • Catheter
  • Others

           By Surgery Type

  • Endovascular Surgery
  • Coiling
  • Stenting
  • Open Surgery
  • Clipping
  • Vessel Bypass

           By End User

 

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3333
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Subarachnoid Hemorrhage Surgical Devices Market size is poised to witness lucrative growth rate during the forecast period i.e., between 2024-2036.

Rising prevalence of SAH and growing R&D investment for medical research will impel the market growth.

North America is predicted to account for largest revenue share by 2036, on the back of availability of advanced health equipment and technology in the region, along with higher healthcare expenditure.

The major players in the market are Stryker Corporation, Abbott Laboratories, General Electric Company, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample